Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Total Liabilities (2009 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) recorded Total Liabilities of $4.2 billion in Q2 2026, up 4.8% from $4.01 billion a year earlier and up 3.7% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Total Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Alnylam Pharmaceuticals reported Total Liabilities of $4.18 billion, up 0.1% from FY2024.

  • Annual Total Liabilities has increased for eight straight years, with a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
  • Across earlier years, Total Liabilities came in at $4.17 billion in FY2024 (+3.0%), $4.05 billion in FY2023 (+9.3%), $3.7 billion in FY2022 (+21.3%) and $3.06 billion in FY2021 (+27.8%).
  • Quarterly Total Liabilities has ranged from $2.72 billion in Q3 2021 to $4.62 billion in Q3 2025 over the past five years.
  • On a year-over-year basis, Total Liabilities has increased for four consecutive quarters, with growth averaging 2.9% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 32.6% in Q3 2022, against a decline of 6.3% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.05 billion (Q1 2026), $4.18 billion (Q4 2025) and $4.62 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 116.09 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 141.05 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 65.46 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 7.18 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 4.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.20 Bn
Mar 31, 2026 4.05 Bn
Dec 31, 2025 4.18 Bn
Sep 30, 2025 4.62 Bn
Jun 30, 2025 4.01 Bn
Mar 31, 2025 3.79 Bn
Dec 31, 2024 4.17 Bn
Sep 30, 2024 4.17 Bn
Jun 30, 2024 4.01 Bn
Mar 31, 2024 4.04 Bn
Dec 31, 2023 4.05 Bn
Sep 30, 2023 4.00 Bn
Jun 30, 2023 3.81 Bn
Mar 31, 2023 3.65 Bn
Dec 31, 2022 3.70 Bn
Sep 30, 2022 3.60 Bn
Jun 30, 2022 3.15 Bn
Mar 31, 2022 3.03 Bn
Dec 31, 2021 3.06 Bn
Sep 30, 2021 2.72 Bn
API Access

Alnylam Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ALNY&period=max&api_key=YOUR_API_KEY